Can You Stay on 5mg Mounjaro for Weight Loss?

The decision your prescriber is actually making at 5mg

When your prescriber looks at whether to keep you on 5mg, increase your dose, or revisit the plan entirely, they are weighing three things: how much weight you are losing, how you are feeling on the medicine, and whether there is a clinical reason to push further. There is a common misconception that moving up the dose ladder is simply what you do on a schedule — tick four weeks, move to the next pen. That is not how it works. Titration is a clinical decision, not a calendar event.

The dose that produces the best outcome for you is the one where meaningful weight loss continues at a level of tolerability you can sustain. For some people that is 5mg. For others, 5mg is a stepping stone. Both are legitimate. The goal is not the highest dose; it is the right dose.

Practically, your prescriber will look at evidence of your current weight at each repeat and review whether progress is happening. If the 5mg pen is delivering steady loss and side effects are manageable, there is no clinical imperative to escalate. The 5mg strength activates both GIP and GLP-1 receptors and suppresses appetite substantially, it is not a weak dose.

What the trial data says about staying at lower therapeutic doses

The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised thousands of adults with obesity across tirzepatide doses including 5mg, 10mg and 15mg alongside placebo. At 5mg, participants achieved around 15% average body-weight reduction over 72 weeks, a clinically significant result by any measure. The headline figure of roughly 20–21% average loss came from the 15mg arm, but the gap does not make 5mg ineffective; it makes it the lowest dose with a strong evidence base for meaningful weight loss.

That context matters when you are deciding whether to stay put. If you are losing weight steadily on 5mg, the trial data supports that as a real therapeutic position, not a compromise. Mounjaro's dual mechanism (acting on both GIP and GLP-1 receptors) is already operating at 5mg, reducing appetite and slowing gastric emptying in ways that support sustained lower calorie intake.

What the evidence also shows is that higher doses produce greater average loss on a population level. So if your weight loss has slowed or stopped, moving to 7.5mg is the next option your prescriber will consider. You can read more about staying at 7.5mg if that is where your conversation is heading.

Side effects and tolerability at 5mg: what to expect

Most people find that side effects are most noticeable in the first few weeks at any new dose, then settle. At 5mg the typical picture is gastrointestinal: nausea, loose stools, indigestion, and sometimes fatigue or burping. These generally ease as your body adjusts. They do not mean the medicine is harming you, but they are worth discussing with your prescriber if they are persistent or affecting your quality of life.

If you came up from 2.5mg and found that transition rough, staying at 5mg until tolerance improves is a sensible clinical position. The NHS medicines information for tirzepatide covers common and serious side effects in detail and is worth reading alongside your patient information leaflet. Any side effect you are unsure about is worth raising, that is exactly what aftercare support is for.

One signal worth taking seriously: severe, persistent stomach pain that radiates toward the back, with or without vomiting. That warrants urgent medical attention. It is rare, but the MHRA has highlighted acute pancreatitis as an infrequent but serious risk with GLP-1 medicines and you should not wait it out at home.

Staying on 5mg versus starting there: does it matter how you arrived?

Some people ask whether staying on 5mg is different depending on whether they started at 2.5mg and titrated up, or whether they began at 5mg directly. Clinically, the dose strength is what matters, not the route you took to reach it. What does matter is that any decision about your current dose is made with a full picture of your health, your progress to date, and your tolerance, all things a prescriber looks at each time they review your repeat.

If you are thinking about the cost side of staying on 5mg rather than moving up, the cost of Mounjaro by dose is worth understanding too, since higher doses come at higher prices. That is a factor some patients weigh alongside clinical considerations, and it is a fair question to raise with your prescriber.

The short answer is this: staying on 5mg is a clinically valid choice when weight loss is progressing and you are tolerating the medicine. It is not settling. A prescriber who reviews your progress will tell you whether it remains the right call. If you have not yet started treatment, a free consultation is the place to begin that conversation.